Bio-Rad Laboratories, Inc.  

(Public, NYSE:BIO)   Watch this stock  
Find more results for BIO
142.99
-0.52 (-0.36%)
Jul 22 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 142.41 - 144.11
52 week 122.03 - 152.32
Open 143.76
Vol / Avg. 103,486.00/109,708.00
Mkt cap 4.17B
P/E 39.18
Div/yield     -
EPS 3.65
Shares 24.27M
Beta 0.99
Inst. own 77%
Aug 3, 2016
Q2 2016 Bio Rad Laboratories Inc Earnings Call - 5:00PM EDT - Add to calendar
Aug 3, 2016
Q2 2016 Bio Rad Laboratories Inc Earnings Release - 4:00PM EDT - Add to calendar
Jun 7, 2016
Bio Rad Laboratories Inc at Jefferies Healthcare Conference
May 5, 2016
Q1 2016 Bio Rad Laboratories Inc Earnings Call - Webcast
May 5, 2016
Q1 2016 Bio Rad Laboratories Inc Earnings Release
Apr 27, 2016
Bio Rad Laboratories Inc Annual Shareholders Meeting (Estimated)
Apr 26, 2016
Bio Rad Laboratories Inc Annual Shareholders Meeting
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 2.61% 5.60%
Operating margin 5.46% 8.23%
EBITD margin - 14.78%
Return on average assets 1.32% 3.21%
Return on average equity 1.96% 4.84%
Employees 7,770 -
CDP Score - -

Address

1000 ALFRED NOBEL DR
HERCULES, CA 94547-1811
United States - Map
+1-510-7247000 (Phone)
+1-510-7415817 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Bio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of life science research and clinical diagnostics products. The Company manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Bio-Rad operates in two segments: Life Science and Clinical Diagnostics. The Company's Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. The Company's Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. Bio-Rad sells over 8,000 products and services to a client base consisting of scientific research, healthcare, education and government customers around the world.

Officers and directors

Norman D. Schwartz Chairman of the Board, President, Chief Executive Officer
Age: 70
Bio & Compensation  - Reuters
Christine A. Tsingos Chief Financial Officer, Executive Vice President
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John P. Goetz Chief Operating Officer, Executive Vice President
Age: 66
Bio & Compensation  - Reuters
Michael Crowley Executive Vice President, Global Commercial Operations
Age: 54
Bio & Compensation  - Reuters
Shannon Hall Executive Vice President, President, Life Science Group
Age: 46
Bio & Compensation  - Reuters
John Hertia Executive Vice President, President, Clinical Diagnostics Group
Age: 60
Bio & Compensation  - Reuters
Giovanni Magni Executive Vice President, Chief Strategy Officer
Age: 59
Bio & Compensation  - Reuters
Ronald W. Hutton Vice President, Treasurer
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Alice N. Schwartz Director
Age: 89
Bio & Compensation  - Reuters
Louis C. Drapeau CPA Independent Director
Age: 72
Bio & Compensation  - Reuters